New diabetes clinical trial: Mesenchymal Stem Cells Transplantation in Newly Diagnosed Type-1 Diabetes Patients

Published on: September 05, 2019 at 07:00PM
Conditions:   Diabetes Mellitus;   Diabetes Mellitus, Type 1;   Diabetes Mellitus, Insulin-Dependent
Interventions:   Biological: Intravenous Injection of autologous mesenchymal stem cells;   Other: Intravenous injection of placebo
Sponsors:   Royan Institute;   Tehran University of Medical Sciences;   Iranian Stem Cell Council
Active, not recruiting